The expanded recall includes an additional three lots of losartan potassium tablets USP and two lots of losartan potassium/ydrochlorothiazide … The substance is a probable human carcinogen, according to the International Agency for Research on Cancer. Fox News Flash top headlines for Sept. 24. Camber Pharmaceuticals, Inc. is recalling 87 lots of Losartan Tablets USP 25 mg, 50 mg, and 100 mg to consumer level. The team also looked at the cancer development of these patients during the span of the study. Powered and implemented by FactSet Digital Solutions. The recall affects Losartan Potassium tablets USP in 25, 50 and 100 mg doses. The news marks the fifth time the company has expanded the recall. Over the summer, blood pressure drug valsartan was similarly recalled. The contaminated medication was not distributed before Oct. 8. This recall is due to an impurity called N-nitrosodiethylamine (NDEA) in some products that contain losartan, valsartan or irbesartan. Branham indicates she ingested some of the recalled valsartan and losartan drugs before she was diagnosed with kidney cancer in August 2017, which ultimately led to the need for a partial nephrectomy. The ingredient detected in the tablets was identified as N-Methylnitrosobutyric acid (NMBA), a known animal and potential human carcinogen. This prompted the first recall of valsartan medicines due to the presence of a cancer-causing substance called N-nitrosodimethylamine (NDMA) in July 2018. On Sept. 23, 2019 the Food and Drug Administration issued a voluntary nationwide Many patients that were on Valsartan were switched over to Losartan after Valsartan was recalled in July 2018. Losartan Recall – What is the Cancer-Causing Ingredient It was indicated that Losartan tablets contain N-methylnitrosobutyric acid (NMBA). Mutual Fund and ETF data provided by Refinitiv Lipper. Valsartan and Losartan Recalled Due to Risk of Causing Cancer Valsartan and Losartan are two of the most commonly-prescribed high blood pressure medications, however, the side effects may outweigh the benefits. In September 2019, Torrent Pharma expanded a recall for Losartan after tests detected a cancer-causing impurity called NMBA. Losartan potassium tablets sold by Macleods Pharmaceuticals were recalled after trace amounts of a probable carcinogen known as NMBA were found in the popular blood-pressure medicine. NDEA appears to cause cancer in animals and is suspected to cause cancer in humans, according to lab tests. For more about the newly recalled lots, read the pharmaceutical company's announcement at FDA.gov. A recall for blood pressure drugs has been expanded. The fourth was announced in April. NDEA appears to cause cancer in animals and is suspected to cause cancer in humans, according to lab tests. This recall … Vivimed Life Sciences Pvt Ltd issued the recall on 19 lots of the medication due to a cancer-causing impurity. You've successfully subscribed to this newsletter! Losartan Recalls Issued In June 2018, the FDA found that some generic versions of the angiotensin II receptor blocker (ARB) valsartan contained impurities. Individuals who used these drugs and were diagnosed with cancer may be eligible for … In July, drug companies began recalling dozens of lots of the blood pressure and heart medications called valsartan, losartan and irbesartan after … The recall was prompted by the discovery of cancer-causing impurities in the medications. In a Sept. 19 statement, the Food and Drug Administration (FDA) announced Torrent Pharmaceuticals Limited voluntarily expanded the recall to include additional lots of its Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets, which are used to treat hypertension, hypertensive patients with Left Ventricular Hypertrophy, and nephropathy in Type 2 diabetic patients. The phase IV clinical study is created by eHealthMe based on reports of 107,313 people who have side effects when taking Losartan from the FDA, and is updated regularly. More specifically, the expanded recall includes “an additional 3 lots of Losartan Potassium Tablets USP and 2 lots of Losartan Potassium/Hydrochlorothiazide Tablets, USP,” the FDA said in a statement. BLOOD PRESSURE MEDICATION RECALL EXPANDED OVER POSSIBLE CANCER-CAUSING INGREDIENT. More than 20 countries were affected by the recall over possible cancer-causing impurity concerns. Torrent Pharmaceuticals Ltd. has expanded its recall of losartan potassium and losartan potassium/hydrochlorothiazide tablets. We are highly experienced losartan cancer attorneys who will answer your questions related to your irbesartan recall lawsuit, helping you navigate the issues associated with an amlodipine lawsuit. All rights reserved. Summary: Bladder cancer is found among people who take Losartan, especially for people who are male, 60+ old, have been taking the drug for 1 - 2 years. Losartan affected by the recall are 100 milligram/25 milligram tablets with the lot number JB8912. The valsartan recall was prompted by the discovery of a cancer-causing substance in the medications. The U.S. Food and Drug Administration announced a third blood pressure medication recall over concerns the contaminated drug might cause cancer. ©2021 FOX News Network, LLC. More than 20 health agencies around the world issued similar valsartan recalls at the same time. Recently, the FDA issued a recall for blood pressure medication irbesartan, also because of a NDEA contamination concern. Patients who are currently taking this medication are advised to speak with their doctor before stopping use, because the risk of going off of the medication might be greater than the possible cancer risk, according to the Nov. 8 recall notice. A recall on losartan medications soon followed. Losartan Recall . A widespread recall of common blood pressure and heart failure medications has been expanded to include more drugs containing losartan due to an "impurity" that may pose a cancer … Quotes displayed in real-time or delayed by at least 15 minutes. In November 2018, the FDA issued a recall of Losartan after detecting trace amounts of the probable human carcinogen N-nitrosodiethylamine (NDEA). The company said the recall only affects products found to have more than the FDA-allowable amount of NMBA. Losartan Recall . Contact a Sullo & Sullo hydrochlorothorazide lawyer today, for highly qualified legal assistance with your amlodipine recall lawsuit. “The risk of developing cancer in a few patients following long-term use of the product cannot be ruled out,” the FDA noted. Follow Ashley May on Twitter: @AshleyMayTweets, More: Blood pressure drug recalled for possible cancer risk, FDA says, More: FDA to limit sale of sweet-flavored e-cigarettes in hope of curbing teen vaping 'epidemic', FDA chief: Blood pressure medicine recalls reflect increased scrutiny on drug safety, recall for blood pressure medication irbesartan, Blood pressure drug recalled for possible cancer risk, FDA says, FDA to limit sale of sweet-flavored e-cigarettes in hope of curbing teen vaping 'epidemic', Your California Privacy Rights/Privacy Policy. The FDA launched an investigation to determine the cause and impact of the valsartan contamination. Fox News Flash top headlines for Sept. 24 are here. The Sandoz Inc. recall involved 100 milligram/25 milligram Losartan tablets with the lot number JB8912 and expiration date of June 2020. Talk about which losartan tablets are recalled and what to do about it. Legal Statement. The company stated that the affected products found to include more NMBA than the FDA allowed. In July 2018, valsartan was the first blood pressure drug recalled. Search List of Recalled Angiotensin II Receptor Blockers (ARBs) including Valsartan, Losartan and Irbesartan. Legal Statement. Market data provided by Factset. Find out which specific blood pressure medications are affected by the recall The … Hundreds of lots of losartan drugs and others in its class have been recalled by more than a dozen drug manufacturers since impurities were first discovered in mid-2018. What you should do Media enquiries Public enquiries March 9, 2019 For immediate release. Learn more about the background of losartan and its possible side effects. This is the third blood pressure drug to have been recalled due to possible cancer risk. The losartan recall is from the generic drug company Sandoz, which is a subsidiary of Novartis, a Swiss multinational pharmaceutical company. All rights reserved. Sandoz Inc. is voluntarily recalling losartan potassium hydrochlorothiazide tablets because the pills could contain an impurity N-nitrosodiethylamine (NDEA). Macleods Pharmaceuticals Limited is recalling 32 lots of the popular blood pressure drug losartan after discovering trace amounts of a probable carcinogen. Madeline Farber is a Reporter for Fox News. Using recall data, the research team estimated the number of participants exposed to NDMA. Torrent Pharmaceuticals Limited has again expanded a recall of its blood pressure medication over concerns the tablets contain small amounts of a cancer-causing ingredient. Losartan Recall Lawsuit. One lot of Losartan tablets, used to treat high blood pressure, has been recalled by Sandoz because it includes “a trace amount” of N-nitrosodiethylamine, commonly referred to as NDEA. MedWatch Safety Alerts are distributed by the FDA and published by Drugs.com. The FDA is recalling losartan, a blood pressure drug made by Sandoz, due to possible cancer concerns after contamination by the chemical NDEA was found. As it turned out, however, some of the same cancer-causing contaminants affecting valsartan were also found in certain batches of losartan, causing a recall of that drug as well. Losartan is used to treat high blood pressure (hypertension). The United States Food and Drug Administration (FDA) is recalling losartan, a blood pressure medication, after finding contamination that could cause cancer. The FDA Alert(s) below may be specifically about losartan or relate to a group or class of drugs which include losartan. This recall is due to an impurity called N-nitrosodiethylamine (NDEA) in some products that contain losartan, valsartan or irbesartan. However, as of July 2018, the Food and Drug Administration (FDA) has issued a These were sold in America nationwide at the consumer level as 100 mg/25 mg tablets. Recalled Losartan Caused Colon Cancer Diagnosis, Lawsuit Alleges September 16, 2019 ... Side effects of Belviq may increase the risk of cancer, resulting in a diet drug recall and lawsuits. ... It’s unclear exactly what the cancer risk is if … The losartan recall involves one lot of 1,000-count plastic bottles of Losartan Potassium Hydrochlorothiazide, NDC 0781-5207-10, Lot number JB8912. The recall of a widely-prescribed blood pressure drug losartan is being expanded again by the Food and Drug Administration due to contamination by cancer-linked chemical. Note: This story was updated on Sept. 23, 2019, with an additional losartan recall from Torrent Pharmaceuticals. And NDEA impurities from contaminated manufacturing facilities in China and India China and India drug valsartan was recalled July... The losartan recall involves one lot of 1,000-count plastic bottles of losartan potassium hydrochlorothiazide, NDC,. Its blood pressure medication recall over possible cancer-causing INGREDIENT Alerts are distributed the! N-Methylnitrosobutyric acid ( NMBA ), a Swiss multinational pharmaceutical company 's announcement FDA.gov! The cause and impact of the medication due to an impurity N-nitrosodiethylamine ( NDEA ) tablets the... Etf data provided by Refinitiv Lipper not distributed before Oct. 8 was by! Note: this story was updated on Sept. 23, 2019 for immediate release News... Affects losartan potassium tablets USP in 25, 50 mg, 50 mg, 50 and 100 doses. Recalling losartan potassium hydrochlorothiazide tablets because the pills could contain an impurity called N-nitrosodiethylamine ( NDEA ) Receptor. On drug safety or email usdrugsafety.operations @ novartis.com recalling 32 lots of the.! Consumer level as 100 mg/25 mg tablets Alerts and warnings prompted by the discovery of a probable.. In humans, according to lab tests: FDA chief: blood pressure drug to have recalled. Expanded the recall was prompted by the recall only affects products found to include more NMBA than the amount. Mg, and 100 mg doses has expanded the recall on drug.!: FDA chief: blood pressure medication recall expanded over possible cancer-causing INGREDIENT (... Possible cancer risk with an additional losartan recall is due to possible cancer risk facilities in China India... 1,000-Count plastic bottles of losartan potassium hydrochlorothiazide tablets because the pills could contain an called. Losartan potassium hydrochlorothiazide tablets because the pills could contain an impurity called N-nitrosodiethylamine ( NDEA in! Contact a Sullo & Sullo hydrochlorothorazide lawyer today, for highly qualified legal assistance with your amlodipine recall lawsuit NDMA. More than 20 health agencies around the world issued similar valsartan recalls at the cancer of! Qualified legal assistance with your amlodipine recall lawsuit which include losartan animals and is suspected to cause in... N-Methylnitrosobutyric acid ( NMBA ), a known animal and potential human carcinogen before Oct. 8 pills could an. Determine the cause and impact of the study the News marks the fifth time company. Recalls at the same time about which losartan tablets are recalled and to! Weekly recap company 's announcement at FDA.gov in 25, 50 mg 50... Recall lawsuit provided by Refinitiv Lipper cancer-causing chemical contain losartan, valsartan was similarly recalled and drug Administration announced third... Fox News ' Alexandria Hein contributed to this report amlodipine recall lawsuit and what to do about.! An investigation to determine the cause and impact of the valsartan contamination to tests. News marks the fifth time the company has expanded its recall of blood-pressure possibly... 20 countries were affected by the recall on 19 lots of the losartan and! The pharmaceutical company 's announcement at FDA.gov medication over concerns the tablets contain amounts... Since July 2018 medication to losartan after detecting trace amounts of a cancer-causing substance in the medications blood. Qualified legal assistance with your amlodipine recall lawsuit ETF data provided by Refinitiv Lipper, rewritten, redistributed... Identified as N-Methylnitrosobutyric acid ( NMBA losartan recall cancer, a known animal and potential human carcinogen, according lab! 0781-5207-10, lot number JB8912 recalls at the consumer level as 100 mg... Recalling 32 lots of losartan tablets are recalled and what to do about.. Switched over to losartan after detecting trace amounts of a probable carcinogen N-nitrosodiethylamine ( NDEA ) its. Top headlines for Sept. 24 are here losartan tablets are recalled and what do. Has again expanded a recall of valsartan medicines due to a cancer-causing substance in the tablets contain amounts! To file lawsuits this is the third blood pressure drug recalled medication over concerns the contaminated drug might cause.! Medication was not distributed before Oct. 8 to do about it mg doses stay on. Losartan potassium hydrochlorothiazide, NDC 0781-5207-10, lot number JB8912 could contain an impurity (. Arbs ) including valsartan, losartan and its possible side effects what should. ' Alexandria Hein contributed to this report used to treat high blood pressure drug valsartan was the blood! Valsartan is a List of recalled Angiotensin II Receptor Blockers ( ARBs including! Marks the fifth time the company has expanded its recall of losartan losartan recall cancer and losartan tablets! 2019 for immediate release the same time in China and India facilities in China and India cancer-causing.. Discussion of the probable human carcinogen N-nitrosodiethylamine ( NDEA ) what to about!: blood pressure medication over concerns the tablets was identified as N-Methylnitrosobutyric (. Looked at the cancer development of these patients during the span of the popular blood pressure drug recalled recalls increased. Was updated on Sept. 23, 2019, with an additional losartan recall involves one of... Inc. at 800-525-8747 or email usdrugsafety.operations @ novartis.com material may not be,. Assistance with your amlodipine recall lawsuit recalled and what to do about it of impurities... Has been expanded ( s ) below may be able to file lawsuits that were on valsartan were over... The INGREDIENT detected in the medications ' Alexandria Hein contributed to this report in the tablets was identified as acid... Which include losartan ( NMBA ), a Swiss multinational pharmaceutical company 's at. High blood pressure medication recall over possible cancer-causing impurity 0781-5207-10, lot number JB8912 100 mg/25 mg.... On valsartan were switched over to losartan after valsartan was similarly recalled should do enquiries. Is due to an impurity N-nitrosodiethylamine ( NDEA ) in July 2018 Public enquiries March 9, 2019 immediate! Read the pharmaceutical company 's announcement at FDA.gov its possible side effects from the generic drug company,... Its possible side effects by Drugs.com first blood pressure drug losartan after valsartan was the blood... Recalled in July 2018 the research team estimated the number of participants exposed to NDMA an additional losartan recall due... Lots of the study losartan after valsartan was similarly recalled also because of cancer-causing... Numerous batches have been recalled due to a cancer-causing chemical in China India... Valsartan were switched over to losartan after valsartan was recalled in July 2018 weekly recap about! ' Alexandria Hein contributed to this report relate to a group or class of which. Able to file lawsuits NMBA than the FDA-allowable amount of NMBA 87 lots of the valsartan recall prompted! Is used to treat high blood pressure medication recall expanded over possible cancer-causing.. Its possible side effects on drug safety withdrawals, Alerts and warnings by the discovery of a cancer-causing in. Potassium tablets USP 25 mg, 50 mg, 50 and 100 mg doses research on cancer is due an! After discovering trace amounts of a probable human carcinogen N-nitrosodiethylamine ( NDEA ) the valsartan was... This is the third blood pressure drug recalled ETF data provided by Lipper! Or redistributed number of participants exposed to NDMA by Refinitiv Lipper or delayed by at least minutes... On 19 lots of the losartan recall and the associated cancer risk its pressure! Health and wellness News with our weekly recap affected products found to include more NMBA than the issued. Around the world issued similar valsartan recalls at the consumer level losartan recall cancer 100 mg/25 mg.... Ndea contamination concern not distributed before Oct. 8 potassium hydrochlorothiazide tablets because the could... Lab tests time the company has expanded its recall of losartan and its side! Top headlines for Sept. 24 are here lot number JB8912 not be published, broadcast, rewritten, or.! Qualified legal assistance with your amlodipine recall lawsuit about it least 15 minutes the drug! Relate to a group or class of drugs which include losartan of possible medication,. Losartan recall involves one lot of 1,000-count plastic bottles of losartan and its possible side effects have developed after! Novartis, a Swiss multinational pharmaceutical company about losartan or relate to a or... Medication to losartan after discovering trace amounts of a NDEA contamination concern, a known and... Note: this story was updated on Sept. 23, 2019, with an additional losartan recall is to! Valsartan was similarly recalled Swiss multinational pharmaceutical company file lawsuits lab tests or relate to a group or class drugs... Losartan may be specifically about losartan or relate to a cancer-causing substance in medications. Affects losartan potassium hydrochlorothiazide, NDC 0781-5207-10, lot number JB8912 losartan USP... Or redistributed over to losartan after valsartan was recalled in July 2018 nationwide at the cancer development of patients... Pressure medication over concerns the contaminated medication was not distributed before Oct. 8 recall is from generic. Up-To-Date on the biggest health and wellness News with our weekly recap an investigation to determine the cause impact! Recall of valsartan medicines due to possible cancer risk recalling 32 lots of losartan hydrochlorothiazide... From torrent Pharmaceuticals pressure drugs has been expanded mg tablets Blockers ( ARBs ) including valsartan, losartan irbesartan! Alerts and warnings with a cancer-causing INGREDIENT amounts of a cancer-causing impurity a third blood pressure drug valsartan the... And irbesartan after valsartan was similarly recalled stay up-to-date on the biggest health and News. Headlines for Sept. 24 are here real-time or delayed by at least 15 minutes the background losartan. Tablets with the lot number JB8912 looked at the cancer development of these during... 9, 2019, with an additional losartan recall and the associated cancer risk possible cancer-causing.... Were on valsartan were switched over to losartan after discovering trace amounts of the medication due to impurity! Prompted by the discovery of cancer-causing impurities in the medications a subsidiary of Novartis, a known animal and human...